Antiphospholipid syndrome — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Specialist review for intensified warfarin or low-molecular-weight heparin
Recurrent thrombosis despite therapeutic warfarin requires confirmation of adherence, INR quality and the event, followed by specialist consideration of a higher INR target, low-molecular-weight heparin or selected adjunctive aspirin. Direct oral anticoagulants are unsuitable for high-risk APS, particularly triple-positive disease.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/musculoskeletal-conditions